Gemfibrozil
جمفیبروزیل
❤️ Cardiovascular SystemFibrate
Market / country: 🇺🇸 USA
Lopid (US)
🧮 Dose calculator
Hypertriglyceridaemia · Regimen source: FDA Gemfibrozil · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hepatic or severe renal dysfunction (incl. primary biliary cirrhosis); gallbladder disease; hypersensitivity; with simvastatin, repaglinide or selexipag. FDA Gemfibrozil · Contraindications
Important interactions
- • With statins: myopathy and rhabdomyolysis. FDA Gemfibrozil · Warnings
- • Potentiates warfarin. FDA Gemfibrozil · Precautions
Formulations
- 600 mg tablet (scored) — tablet 🇺🇸 USA FDA Gemfibrozil · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Gemfibrozil · Precautions/Warnings – Pregnancy
“Gemfibrozil should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Gemfibrozil · Precautions/Warnings – Nursing Mothers
“Because many drugs are excreted in human milk and because of the potential for tumorigenicity shown for gemfibrozil in animal studies, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. 7.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Gemfibrozil · Precautions/Warnings – Pediatric Use
“Safety and efficacy in pediatric patients have not been established.”
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA079072
- DailyMed (FDA label)FDA Gemfibrozil
- MedlinePlus (NIH)Gemfibrozil
- WHO ATC/DDDC10AB04
- Darooyab (Iran)Gemfibrozil
🇮🇷 Registered in Iran Darooyab · G-1692/Gemfibrozil
Dosage forms with Iranian generic codes, per Darooyab.
- 00584 · GEMFIBROZIL 300MG CAP · کپسول جمفیبروزیل ۳۰۰ میلیگرم
- 01520 · GEMFIBROZIL 450MG TAB · قرص جمفیبروزیل ۴۵۰ میلیگرم
- 12739 · GEMFIBROZIL 600MG TAB · قرص جمفیبروزیل ۶۰۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Gemfibrozil · How SuppliedFDA Gemfibrozil · Dosage and AdministrationFDA Gemfibrozil · ContraindicationsFDA Gemfibrozil · WarningsFDA Gemfibrozil · PrecautionsFDA Gemfibrozil · Precautions/Warnings – PregnancyFDA Gemfibrozil · Precautions/Warnings – Nursing MothersFDA Gemfibrozil · Precautions/Warnings – Pediatric UseFDA Gemfibrozil · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1692/Gemfibrozil
- Clinical review⚠ Unverified